Cystic Fibrosis

Q: What are the recommendations for nutrition screening, assessment and monitoring in children and adults with cystic fibrosis?

Q: Do infants, children and adults with cystic fibrosis (CF) have higher energy and macronutrient requirements compared to healthy infants, children and adults without CF?

Q: What are the recommendations for fat-soluble vitamins in individuals with cystic fibrosis?

Q: What are the recommendations for mineral supplementation in individuals with cystic fibrosis?

Q: What type of nutrition interventions are effective in supporting optimal growth and weight gain in children and adults with cystic fibrosis? When are oral calorie supplements or enteral supplementation indicated?

Q: What are the recommendations for pancreatic enzyme replacement therapy (PERT) in individuals with cystic fibrosis?

Q: What is the recommended nutrition management for the most common nutrition-related medical problems in cystic fibrosis (CF) (e.g. CF-related diabetes, low bone density)?

Q: Do individuals with cystic fibrosis (CF) who supplement their diets with omega-3 fatty acid supplements (containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) have improved health outcomes compared with individuals with CF not consuming omega-3 fatty acid supplements?

Q: Do individuals with cystic fibrosis (CF) who supplement their diets with probiotics have improved health outcomes compared with individuals with CF not using probiotics?